Relationship of metabolic and endocrine parameters to brain glucose metabolism in older adults: do cognitively-normal older adults have a particular metabolic phenotype?

Biogerontology

Volumn 17, Issue 1, 2016, Pages 241-255

  Nugent, S ^a   Castellano, C A ^a   Bocti, C ^a   Dionne, I ^a   Fulop, T ^a   Cunnane, S C ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Aging; Brain; Cognition; Energy metabolism; Glucose; MRI; Positron emission tomography

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; HORMONE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY FAT; BRAIN METABOLISM; BRAIN SIZE; CAUDATE NUCLEUS; COGNITION; COGNITION ASSESSMENT; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); FEMALE; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; LIPID COMPOSITION; MALE; METABOLIC RATE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ADIPOSE TISSUE; AGED; AGING; ANTIBODY SPECIFICITY; BLOOD; BRAIN; ENERGY METABOLISM; METABOLIC CLEARANCE RATE; METABOLISM; PHYSIOLOGY; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION;

ADIPOSE TISSUE; ADULT; AGED; AGING; BRAIN; COGNITION; ENERGY METABOLISM; FEMALE; GLUCOSE; HORMONES; HUMANS; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; PHENOTYPE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE AND ORGAN PROCUREMENT;

EID: 84955416036     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-015-9595-7     Document Type: Article

References (45)

1. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68:51–57. doi:10.1001/archneurol.2010.225
2. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279–284
3. Chetelat G et al (2013) Relationships between brain metabolism decrease in normal aging and changes in structural and functional connectivity. Neuroimage 76:167–177. doi:10.1016/j.neuroimage.2013.03.009
4. Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 66:300–305. doi:10.1001/archneurol.2009.27
5. Craft S, Cholerton B, Baker LD (2013) Insulin and Alzheimer’s disease: untangling the web. J Alzheimer’s Dis 33(Suppl 1):S263–S275. doi:10.3233/JAD-2012-129042
6. Cunnane S et al (2011) Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition 27:3–20. doi:10.1016/j.nut.2010.07.021
7. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis I. Segmentation and surface reconstruction. Neuroimage 9:179–194. doi:10.1006/nimg.1998.0395
8. Delis D, Kaplan E, Kramer J (2001) Delis–Kaplan executive function system (D-KEFS). The Psychological Corporation, San Antonio
9. Destrieux C, Fischl B, Dale A, Halgren E (2010) Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage 53:1–15. doi:10.1016/j.neuroimage.2010.06.010
10. De Santi S et al (1995) Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatr q 66:357–370
11. Fischl B, Liu A, Dale AM (2001) Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 20:70–80. doi:10.1109/42.906426
12. Fischl B et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355
13. Fischl B et al (2004) Automatically parcellating the human cerebral cortex. Cereb Cortex 14:11–22
14. Fjell AM et al (2009) One-year brain atrophy evident in healthy aging. J Neurosci 29:15223–15231. doi:10.1523/JNEUROSCI.3252-09.2009
15. Frisardi V et al (2010) Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer’s disease. Ageing Res Rev 9:399–417. doi:10.1016/j.arr.2010.04.007
16. Garraux G, Salmon E, Degueldre C, Lemaire C, Laureys S, Franck G (1999) Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 10:149–162. doi:10.1006/nimg.1999.0463
17. Graham MM, Muzi M, Spence AM, O’Sullivan F, Lewellen TK, Link JM, Krohn KA (2002) The FDG lumped constant in normal human brain. J Nucl Med 43:1157–1166
18. Hedden T, Gabrieli JD (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5:87–96. doi:10.1038/nrn1323
19. Herholz K et al (2002) Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17:302–316
20. Jernigan TL, Archibald SL, Fennema-Notestine C, Gamst AC, Stout JC, Bonner J, Hesselink JR (2001) Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging 22:581–594
21. Kalpouzos G et al (2009) Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30:112–124. doi:10.1016/j.neurobiolaging.2007.05.019
22. Lee A, Ratnarajah N, Tuan TA, Chen SH, Qiu A (2015) Adaptation of brain functional and structural networks in aging. PLoS One. doi:10.1371/journal.pone.0123462
23. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191–2192
24. Moeller JR et al (1996) The metabolic topography of normal aging. J Cereb Blood Flow Metab 16:385–398. doi:10.1097/00004647-199605000-00005
25. Mosconi L et al (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease. J Nucl Med 47:1778–1786
26. Nugent S et al (2014a) Glucose hypometabolism is highly localized but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults. Am J Physiol Endocrinol Metab. doi:10.1152/ajpendo.00067.2014
27. Nugent S et al (2014b) Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiol Aging 35:1386–1395. doi:10.1016/j.neurobiolaging.2013.11.027
28. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1–7. doi:10.1038/jcbfm.1983.1
29. Petit-Taboue MC, Landeau B, Desson JF, Desgranges B, Baron JC (1998) Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 7:176–184. doi:10.1006/nimg.1997.0318
30. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol 6:371–388. doi:10.1002/ana.410060502
31. Qizilbash N et al (2015) BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. doi:10.1016/S2213-8587(15)00033-9
32. Quarantelli M et al (2004) Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 45:192–201
33. Reiman EM et al (1996) Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334:752–758. doi:10.1056/NEJM199603213341202
34. Reiman EM et al (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer’s disease. Ann Neurol 44:288–291. doi:10.1002/ana.410440226
35. Scholl M et al (2011) Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiol Aging 32:1388–1399. doi:10.1016/j.neurobiolaging.2009.08.016
36. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B (2004) A hybrid approach to the skull stripping problem in MRI Neuroimage 22:1060–1075. doi:10.1016/j.neuroimage.2004.03.032
37. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87–97. doi:10.1109/42.668698
38. Wartofsky L, Dickey RA (2005) The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 90:5483–5488. doi:10.1210/jc.2005-0455
39. Wechsler D (1997) Wechsler memory scale, 3rd edn. The Psychological Corporation, San Antonio
40. Wechsler D (2008) WAIS-IV administration and scoring manual. The Psychological Corporation, San Antonio
41. Westman E, Aguilar C, Muehlboeck JS, Simmons A (2013) Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer’s disease and mild cognitive impairment. Brain Topogr 26:9–23. doi:10.1007/s10548-012-0246-x
42. WHO (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. World Health Organization, Geneva
43. Zhou S, Chen K, Reiman EM, Li DM, Shan B (2011) A method of generating image-derived input function in a quantitative (1)(8)F-FDG PET study based on the shape of the input function curve. Nucl Med Commun 32:1121–1127. doi:10.1097/MNM.0b013e32834abd1b
44. Zou Y et al (2013) Vascular risk factors and mild cognitive impairment in the elderly population in Southwest China. Am J Alzheimers Dis Other Demen. doi:10.1177/1533317513517042
45. Zuendorf G, Kerrouche N, Herholz K, Baron JC (2003) Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Hum Brain Mapp 18:13–21. doi:10.1002/hbm.10069